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Abstract.  The rat bladder carcinoma cell line NBT-II 
exhibits two completely different responses to acidic 
FGF (aFGF): at high cell density, aFGF is a potent 
mitogen whereas at low cell density, aFGF acts as a 
scattering agent that can convert the epithelial NBT-II 
cells into fibroblastic-like, motile cells. The basis of 
the dual action of aFGF has been approached by using 
substances interfering  with the transducing  pathways 
known to be activated by growth factors.  Genistein 
and tyrphostin,  two inhibitors of tyrosine kinases,  in- 
hibit both cell scattering and mitogenesis induced by 
aFGE  Conversely, sodium orthovanadate,  a potent in- 
hibitor of tyrosine phosphatases can reproduce the two 
effects of aFGF, indicating that protein tyrosine phos- 
phorylations are determinant  in the two pathways. In 
contrast,  transforming growth factor (TGF)-/51  is a 
strong inhibitor of DNA synthesis induced by aFGF 
but has no effect on cell scattering,  providing evidence 
that the two pathways are divergent.  In an attempt to 
determine the specificity of the pathways of aFGF we 
found that the level of cAMP, which can be externally 
elevated, is of pivotal importance in distinguishing  be- 
tween the two transducing pathways leading to either 
DNA replication or cell dispersion.  Forskolin, 
8-bromo cAMP, dibutyryl-cAMP, and cholera toxin 
are all capable of potentiating the mitogenic effect of 
aFGF while strongly inhibiting  its scattering action. 
Moreover, addition of any of these substances to NBT- 
II cells converted into fibroblasts immediately induces 
their reversion towards an epithelial phenotype. These 
findings support a role for cAMP as a modulator of 
the effects of aFGE  Moreover, basal cAMP synthesis, 
which is not affected by aFGF, is higher in sparse than 
in dense cultures indicating that the level of cAMP de- 
pends on the status of the cell.  Altogether,  these 
results suggest that establishment and maintenance of 
the epithelial state require a precise regulation of 
cAMP level. 
C 
ELL migrations  have been described as a major event 
in tissue formation  and remodeling  that  take place 
during embryonic and adult life. They are also com- 
ponents  of certain pathological  situations  such as invasion 
and metastasis of tumor cells (27). Even though the cellular 
mechanisms  responsible for the acquisition  of cell motility 
are not yet fully understood, it is clear that they are multiple, 
depending  in part on the state of differentiation  of the cells 
induced  to migrate.  One of the most puzzling  examples of 
cellular transformations  leading to cell motility  is provided 
by the  epithelial-mesenchymal  transition  (EMT), J which 
has been characterized  in many morphogenetic processes (13, 
23, 37). In such cases, the acquisition  of cell motility corre- 
lates with dramatic  changes in the program of cell differen- 
tiation:  the cohesive epithelial cells lose their epithelial  fea- 
tures and are converted into individual,  motile fibroblastic 
cells.  Because of the general  importance of EMT,  several 
groups have established in vitro model systems, using well- 
1. Abbreviations used in this paper: aFGE acidic FGF; DE desmoplakin; 
EMT, epithelium-mesenchyme transition; IBMX, 3-isobutyl-l-methylxan- 
thine; TGE transforming growth factor. 
defined cell cultures to approach the individual steps of such 
complex processes (17). The search for inducer molecules of 
these processes has led to the discovery that growth factors, 
primarily known as regulators of cell proliferation,  can also 
stimulate in vitro cell motility (2, 17, 34, 45, 47) and control 
in vivo embryonic EMT (8, 35). Among them, scatter factor 
(SF), which is identical to hepatocyte growth factor (HGF) 
and therefore  elicits  scattering  as well as mitogenic func- 
tions,  is a morphogenetic  factor for aggregates  of MDCK 
cells (29).  These results suggest that factors that have been 
described in vitro as scattering  agents promoting EMT-like 
changes of epithelial  cells could act in vivo as morphogens 
involved in the plasticity  of epithelial  tissues. 
Because many growth factors,  such as SF/HGF, are mul- 
tifunctional  it is important to understand the mechanisms 
that trigger the specificity of the cellular response to a given 
growth factor. Although this question is far from being eluci- 
dated (9) there is a growing body of evidence indicating that 
signal transduction  generated by a given growth factor can 
follow multiple  pathways (40).  The choice of the pathways 
that are activated may be dictated in part by the cell itself. 
We have used the rat bladder carcinoma-derived  cell line 
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multifunctionality of acidic FGF  (aFGF).  On  addition of 
aFGE  subconfluent cultures of NBT-II cells dissociate and 
give rise to individual, elongated, actively migrating cells 
(41), whereas confluent cultures enter mitosis in response to 
the  same  factor  (42).  Similarly,  EGF  had  already  been 
reported to induce confluent cultures of rat intestinal epithe- 
lial cells to proliferate and subconfluent cultures to migrate 
(6). Here, we have analyzed the two biological responses of 
NBT-II cells stimulated by aFGF after treatment with agents 
known to synergize or antagonize second messenger mole- 
cules. Although the transducing pathways activated by the in- 
teraction of peptide hormones, referred to as growth factors, 
with their cognate receptors remain poorly defined, there 
are three major enzymatic activities potentially important in 
the  signaling cascades.  First, tyrosine-specific protein ki- 
nases have been shown to play a role in transducing signals 
of several growth factors which directly bind to receptors 
harboring a tyrosine kinase activity (40). Second, activation 
of phospholipase (PLC) has also been proposed as a primary 
event in signal transduction in response to several growth 
factors (4). The third pathway involves the production of cy- 
clic AMP (cAMP) by stimulated adenylate cyclase (14). Our 
results demonstrate that tyrosine-specific kinase activity is 
central in the two biological responses to aFGE  Further- 
more, a  sustained elevation of cAMP level antagonizes the 
dispersing response to aFGF while potentiating the mito- 
genie action of aFGE These results strongly support the ex- 
istence of second messenger molecules restricted to each bi- 
ological response to aFGE 
Materials and Methods 
Reagents 
Mouse  mAb against vimentin was purchased from Amersham International 
(Buckinghamshire, UK). Mouse mAb against desmosomal proteins des- 
moplakins (DPs) I and II was the generous gift of Professor W. W. Franke 
(German Cancer Research Center, Heidelberg, FRO). Texas red-coupled 
goat anti-mouse IgG (lmmunotech, Marseille, France) was used as second- 
ary antibody. Human recombinant aFGF (22) was kindly provided by Dr. 
M. Jaye (Rh6ne-Poulenc, King of Prussia, PA). FCS was from Biological 
Industries (Kibbutz Beth Haemek, Israel). Forskolin, pertussis toxin, and 
sodium orthovanadate were purchased from Sigma Chemical Co.  (St. 
Louis, MO), cholera toxin from Calbiochem Corporation (La Jolla, CA), 
and genistein from ICN Biochemicals (Cleveland, OH). Transforming 
growth factor (TGF)-81 was obtained from British Biotechnology  Limited 
(Oxford, UK). Tyrphostin AG18 was the generous gift of Dr. A. Levitzki 
(The Alexander Silberman Institute of Life Sciences, Jerusalem, Israel). 
Cell Culture 
The NBT-II  cell line, originally established by Tohoshima and colleagues 
(38), was obtained from Prof. M. Mareei (University Hospital, Ghent, Bel- 
gium). The original tumor from which NBT-II cell line was derived is a 
squamous bladder carcinoma induced by carcinogenesis. Under standard 
conditions of  culture, the cells assume an organization  and morphology  typ- 
ical of epithelial cells. The cells were routinely grown (37~  in 5% CO2) 
in  DME  containing 10%  heat-inaedvated FCS (standard medium), as 
described previously  (7). Sparse/subconfluent/Iow-density  cultures  are 
delined  by 30-50% cell  density,  compared with 100% cell  density  for 
confluenffhigh-density  cultures. 
Cell motility assay was done using videocinematography  as described 
previously (41). 
In Vitro Wound Model 
NBT-II cell monolayers were obtained after 48 h of culture in standard 
medium. They were gently scratched with a Gilson pipette yellow tip, and 
extensively  rinsed with DME to remove all cellular debris. The procedure 
left a ceU-frce  area of substratum  (~wound"). The cultur~ were then allowed 
to grow overnight  in the presence or absence of various factors and reagents. 
The next morning, cultures were rinsed with PBS, stained with Coomassie 
blue, and photographed  on T-MAX 100 film (Eastman Kodak  Co., Roches- 
ter, NY) with an Olympus camera mounted on an inverted microscope 
(l_~itz, Wetzlar, FRG). 
Indirect Immunofluorescence Microscopy 
N'BT-II cells were seeded on glass coverslips. 2 d after plating, standard 
medium was replaced by DME. aFGF (10 ng/ml) plus heparin (10/~g/mi), 
or various reagents were added for 8 h. Subsequently,  cells were fixed and 
processed for irnmunocytochemistry  as described previously (7). 
Mitogenic Assay 
Cells were seeded in 24-well Nunc plates and grown to confluency  in stan- 
dard medium after which the medium was changed to DME for 24 h. The 
cells were then incubated with growth factors or reagents for 24 h. [methyl- 
3H] thymidine (specific activity, 42 Ci/mmol, Amersham) was added at 
1/+Ci/ml  for the last 4 h of  the experiment. At the end of  the labeling  period, 
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Figure 1. l~initiation of DNA  synthesis in confluent NBT-II cells 
is dependent on tyrosine phosphorylation. NBT-H cells arrested by 
serum starvation for 24 h were stimulated for 20 h before a 4 h incu- 
bation with [3H]thymidine.  The number of counts per minute in- 
corporated was determined as indicated in Materials and Methods. 
Each point represents the mean value of three identical wells + 
standard error. In A, cells were stimulated by increasing concentra- 
tions of sodium orthovanadate alone (=) or in conjunction with 0.1 
ng/ml aFGF (~).  In B, cells  were incubated with genistcin  alone 
(m) or  genistein  in  conjunction  with I  ng/ml aFGF (D).  In C, cells 
were incubated with tyrphostin AG18 alone (m), or tyrphostin 
AG18 and I ng/ml aFGF (D). 
The Journal of Cell Biology, Volume 120, 1993  768 Figure 2. Induction of Nffr-II cell dispersion is dependent on tyrosine phosphorylation events. (a-e) DP immunolabeling of NBT-II ceils 
incubated for 8 h with 10 ng/ml aFGF (a), 100 t~M tyrphostin AG18 plus 10 ng/ml aFGF (b), 50/~M genistein +  10 ng/ml aFGF (c), 
100 I~M genistein +  10 ng/ml aFGF (at), or 100 pM sodium orthovanadate (e). After the incubation period with the various reagents, 
cell cultures were fixed and processed for immunofluorescence microscopy. Note the partial loss of DP peripheral immunostaining in c, 
and the persistence of DP immunoreactivity in cell contacts in b and d. (f-h) Penetration of isolated N'BT-II  cells into wounded areas of 
cell monolayers under standard conditions (f), or with 20 ng/ml aFGF (g), or in the presence of 100/~M sodium orthovanadate (h). Bars: 
(a-e) 20 t~m; (f-h) 200 ~m. 
each  culture  plate was washed twice with ice-cold PBS followed  by the addi- 
tion of 1 ml ice-cold 10% TCA and incubated for 30 rain at 4"C. Alter four 
washes with water, cells were solubilized with 0.I N sodium hydroxide, and 
radioactivity was quantitated by liquid scintillation counting. Experiments 
were conducted in triplicate cultures. 
Binding Studies 
Human recombinant aFGF was labeled by a modification of  the chloramine 
T method (21) as described (33). Specific activities of the iodinated ligand 
varied from 960 to 2,150 dpm/fmol of aFGE 
Equilibrium binding assays on NBT-II cells were carried out as previ- 
ously described (41).  When appropriate (see Results), cells were prein- 
cubated for 4  h  in DME containing the reagents to be tested. 
Cyclic AMP Radioimmunoassay 
Go-arrested NBT-II cells were washed with DME and equilibrated for 30 
rain in this medium before the additions indicated in the legend to Table II. 
At the end of the incubation the medium was removed, the cultures were 
rimed twice with ice-cold PBS, and cells were lyscd for 20 rain at 4"C with 
0.5 ml ethanol/5 mM EDTA (2:1). Cell extracts were evaporated and their 
cAMP content was determined using a radioimmunoassay kit obtained from 
ERIA Diagnostics Pasteur (Marnes-la-Coquette, France), after reconstim- 
tion of  the extracts with the sodium acetate buffer, pH 6.2, used in this assay. 
Results 
1~posine Kinases Are of Central Importance in the 
Biological Responses Elicited by aFGF 
As previously described (7, 41), sparse cultures of NBT-II 
cells assume an epithelial organization under standard con- 
ditions of culture. On exposure to aFGE the epithelial clus- 
ters readily dissociate, giving rise to individual, fibroblas- 
tic-like cells that actively migrate.  The overall changes in 
NBT-II cell morphology, appearing after addition of aFGF, 
are highly reminiscent of an EMT (i,e., an eventually revers- 
ible process of conversion between the epithelial and mesen- 
chymal states). In our system we have used the term EMT 
to indicate that NBT-1I cells lose some epithelial characteris- 
tics and acquire certain properties of fibroblastic ceils. We 
also demonstrated that aFGF which is a potent mitogen for 
confluent cultures of NBT-II cells, is unable to promote cell 
division under subconfluent conditions of culture. Other fac- 
tors that were found to induce dispersion of NBT-II cells 
(EGF,  TGF~  IGF-I)  (16  and  A.  M.  Vallds,  unpublished 
results) reproduce the dual function of aFGF under the two 
different culture conditions.  Interestingly, all these scatter 
factors bind to tyrosine kinase receptors. 
Because of the unique property of growth factors activat- 
ing receptor tyrosine kinase to induce either dispersion or 
proliferation of NBT-II cells, we carried out a series of ex- 
periments in which tyrosine kinase activity was specifically 
inhibited or enhanced. Genistein and tyrphostin AG18 were 
used to specifically inhibit protein-tyrosine phosphorylation 
(1, 48) and sodium orthovanadate to inhibit tyrosine phos- 
phatases (19).  As shown in Fig.  1, genistein and tyrphostin 
AG18 dramatically reduced [3H]thymidine incorporation in 
cells stimulated with aFGF. Conversely, sodium orthovana- 
date was a potent mitogen for NWr-II cells. Interestingly, it 
was active on confluent cultures only and had no mitogenic 
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the mitogenic action of aFGF 
without affecting its dispers- 
ing effect. (Upper panel) The 
reinitiation of DNA synthesis 
was  estimated by [~H]thymi- 
dine incorporation  in confluent 
cultures  of cells deprived of 
serum  for 24 h  before addi- 
tion of TGF-~/1 alone (n) or 
in conjunction with  1 ng/ml 
aFGF  (m). The  number  of 
counts  per  minute  incorpo- 
rated was determined as indi- 
cated in Materials and Meth- 
ods. Each point represents the 
mean  value  of three  identi- 
cal  wells  +  standard  error. 
(Lower  panels)  Sparse  cul- 
tures of NBT-II  cells were in- 
cubated  for 8 h  in  standard 
medium without (a)  or with 
TGF-/31  at 10 ng/ml (b). Alter- 
natively, cells were incubated 
for the  same period  of time 
with aFGF at 10 ng/ml alone 
(c) or in conjunction with 10 
ng/ml TGF-#I (d) before fixa- 
tion and processing for immu- 
nofluorescence labeling with 
anti-DP  antibody.  Note  that 
"I'GF-•I  had no effect on the 
accumulation of DP immuno- 
reactivity in lateral contacts of 
control ceils (b) and did not 
perturb  its  internalization in 
cells  stimulated with  aFGF 
(d). Bar, 20 t~m. 
effect  on subcortfluent cultures (data not shown). In addition, 
it markedly increased [3H]thymidine incorporation in cells 
stimulated with aFGF (Fig.  1). These results demonstrated 
that sodium orthovanadate could mimic the mitogenic action 
of aFGF thus suggesting that tyrosine kinase activation was 
a central event in aFGF-induced mitogenesis. The effects of 
the compounds were also tested on the induction of cell dis- 
persion (Fig. 2). Cell dispersion was examined in two ways: 
cell dissociation and acquisition of  motility. Cell dissociation 
was estimated by the modulation of intercellular junctions, 
and specifically by the alteration of desmosomes.  We had 
previously shown that the immunoreactive pattern observed 
with the mAb to desmoplakin (anti-DP), which recognizes 
a  subset of proteins of the desmosomal plaque (15) disap- 
peared from the boundaries of cells dissociated by aFGF (7, 
41).  DP immunoreactivity was redistributed in intracellular 
dots, suggesting that desmosomes were split and internalized 
during the aFGF-induced EMT (e.g., Fig. 2 d). Cell motility 
was estimated by the ability of cells located at the edge of 
an  artificially produced  wound  to  colonize the  wounded 
area. As already stated (7, 42), wound repair was due solely 
to the ability of NBT-II cells to migrate actively into the 
wound and did not depend on cell proliferation. 
As shown in Fig. 2, in the presence of 100 #M tyrphostin 
AG18 aFGF was no longer able to induce the disappearance 
of DP immunoreactivity from cell boundaries.  Genistein 
also fully inhibited cell dissociation when used at 100/~M, 
which was the concentration giving 100% inhibition of  DNA 
synthesis  (see Fig.  1).  The same  doses of tyrphostin and 
genistein blocked cell migration into the wounded areas of 
cultures stimulated by aFGF (data not shown). As tyrphostin 
AG18 and genistein did not reduce the level of DNA synthe- 
sis in cells stimulated with FCS (not shown), their inhibiting 
action of aFGF-induced mitogenesis and cell scattering was 
not due to nonspecific, toxic effects.  Sodium orthovanadate 
alone was able to reproduce the effects of aFGF: it induced 
the dissociation of cell clusters as visualized by the internal- 
ization of DP immunoreactivity. Interestingly, the response 
to sodium orthovanadate was quite rapid, beginning 2 h after 
its addition into the culture medium as compared with the 
response to aFGF which begins 5 h after addition of aFGE 
Although less effective than aFGF, sodium orthovanadate in- 
duced acquisition of cell motility as visualized by the pene- 
tration of isolated cells within wounded areas of cell mono- 
layers (Fig. 2, compare g and h). Thus, because compounds 
interfering with tyrosine phosphorylation cannot distinguish 
between the two pathways involved in transducing the aFGF 
message, our results indicate that tyrosine phosphorylation 
constitutes a central event in both cell scattering and mito- 
genesis induced by aFGE 
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to aFGF  , 
Because it is well established that TGF-~I is a potent growth  e 
inhibitor in many cell types, it was interesting to test whether  ~  5 
it was able to antagonize the effects of aFGF on Nt~-II cells.  ~  4. 
As illustrated in Fig. 3, TGF-~I abolished the mitogenic re- 
sponse elicited by aFGF with 50% inhibition at a low con-  ~ 3 
centration (0.1 ng/ml). In contrast, the dissociating effect of  ~  z. 
aFGF,  when used at a concentration similar to that of the  ~ 1 
mitogenic assay, was not altered by addition of  TGF-B1 tested  , 
within a wide range of concentrations. In Fig. 3 the effect of  0 
addition of 10 ng/ml of TGF-/31 is shown. TGF-/~I  is thus a 
factor that discriminates between the two pathways elicited 
by aFGF stimulation. 
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An Elevation in cAMP Blocks the EMT 
of NBT-II Cells and Potentiates  the Mitogenic 
Response to aFGF 
Another agent which discriminates between the two path- 
ways of  aFGF is intracellular cAMP. The levels of intracellu- 
lar cAMP can be externally manipulated by using various 
toxins and chemicals: 8-bromo cAMP and dibutyryl cAMP 
are diffusible analogs of natural cAMP, forskolin reversibly 
stimulates adenylate cyclase by binding directly to it, cholera 
toxin stimulates a GTP-binding protein that selectively acti- 
vates adenylate cyclase, and pertussis toxin inactivates an in- 
hibitory G protein (39). However, some of these compounds 
might have complex effects; for example, pertussis toxin also 
inactivates a Gp involved in the activation of PLC (31). 
Mitogenesis induced by aFGF was dramatically increased 
in the presence of cAMP-elevating agents (Fig. 4). Cholera 
toxin alone at 10/zg/ml had a mitogenic effect (Fig. 4  C). 
All compounds potentiated the action of aFGF at a concen- 
tration of  aFGF that was either sufficient to induce DNA syn- 
thesis (Fig. 4, C and D) or not (Fig. 4, A and B). The rather 
modest effect of pertussis toxin can be attributed to the fact 
that  the  toxin  interferes  with  two  different  transducing 
pathways. 
Upon exposure of arrested cells to a combination of aFGF 
and one of the cAMP-elevating agents, DNA synthesis was 
reinitiated 7 h after addition of the factors (data not shown). 
Comparison with the lag period of 12-14 h after which aFGF 
was able to induce an increase in [3H]thymidine incorpora- 
tion suggests that cAMP-modulating agents may bypass some 
steps of the pathway leading to cell proliferation. 
None of the cAMP-elevating compounds tested were able 
to induce, alone or in combination with aFGE the reinitia- 
tion of DNA  synthesis  in  cells arrested at  subconfluency 
(data not shown). This result demonstrated that an increase 
in  cAMP,  which  facilitated aFGF-induced mitogenesis at 
confluency, was not sufficient to overcome the inhibitory ac- 
tion of aFGF at subconfluency. 
The effect of cAMP-elevating compounds was also tested 
on induction of EMT initiated by aFGE  Cell dissociation 
was assessed by internalization of DP immunoreactivity in 
cells incubated with a combination of 20 ng/ml aFGE and 
each compound used at a concentration that was the most 
effective in the mitogenic assay. As shown in Fig. 5, cAMP 
analogs,  forskolin, and cholera toxin dramatically affected 
the  internalization  of  DP  immunoreactivity  induced  by 
aFGE Here again, pertussis toxin had a reduced inhibitory 
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Figure 4.  Incorporation of [3H]thymidine in replicating DNA of 
confluent NBT-II  cells arrested by serum starvation for 24 h before 
stimulation with different agents for 20  h  and  incubation with 
[3H]thymidine for  4  h.  (~a) Stimulation  with  cAMP-elevating 
agents at the indicated concentration. (u) Stimulation with cAMP- 
elevating reagents in conjunction with 0.1 ng/ml aFGF (A and B) 
or 1 ng/ml aFGF (C and D). The number of counts per minute in- 
corporated was determined as indicated in Materials and Methods. 
Each point represents the mean value of three identical wells  + 
standard error. 
effect.  The  inhibition  of cell  dissociation  cannot  be  ac- 
counted for by a toxic effect  of the compounds tested because 
they did exert a positive effect on DNA synthesis. 
The same products were assayed on cell motility tested in 
wound healing experiments (Fig. 6). Depending on the com- 
pound, migration of cells within the wound was partially or 
totally abolished. Once again the less pronounced effect was 
obtained with pertussis toxin. Altogether, these data indicate 
that an augmentation in intracellular cAMP content mark- 
edly synergized the mitogenic function of aFGF on NBT-II 
cells while drastically inhibiting its dispersing effect. 
We subsequently examined whether the effects of cAMP- 
elevating agents on aFGF-induced cell responses were due 
to  modifications  in  aFGF  binding  on  NI~-H  cells.  At 
saturating concentrations of the growth factor, the amount of 
cell-surface bound t2SI-aFGF was not affected by preincuba- 
tion of cells with the different compounds tested (Table I). 
Therefore, the biological effects of cAMP-elevating agents 
were not due to changes in the binding of aFGF to its recep- 
tors, and arose most likely from modifications in the signal- 
ing pathways. 
Boyer and Thiery Signaling  in FGF-induced  Cell Dispersion  771 Figure 5. DP immunostaining 
of NBT-II cells incubated for 
8 h with 10 ng/ml aFGF and 
various cAMP-elevating  agents 
before fixation and processing 
for  immunofluorescence mi- 
croscopy.  Cells  were  incu- 
bated  with  10  ng/ml  aFGF 
alone  (a),  or plus  10 izg/ml 
cholera toxin (b), plus lO0 ng/ 
ml  pertussis  toxin  (c),  plus 
lO0  izM  forskolin  (d),  plus 
1  mM  8-bromo  cAMP  (e), 
plus 1  mM dibutyryl-cAMP  (f). 
Bar, 20 izm. 
Cyclic AMP-elevating Agents Can Reverse the 
~broblastic Phenotype Induced by aFGF 
Since  artificial  elevation of the  intracellular  cAMP  level 
completely abolished the transition  towards  a  fibroblastic 
phenotype,  it  was  important  to  investigate  the  effects of 
cAMP-elevating agents on cells that were already established 
in their fibroblastic-like phenotype by long term culture with 
aFGE In the presence of any of the agents tested, the refor- 
mation of intercellular desmosomes was induced very rap- 
idly, with DP immunoreactivity reexpressed at cell bound- 
aries only 2 h after addition of the compounds (Fig. 7). In 
keeping with the effects of pcrtussis toxin on the initiation 
of EMT, this toxin was not very efficient in the reformation 
of desmosomal contacts between cells. Concomitantly with 
the reformation of desmosomes, cells stopped migrating: for 
example, videomicrocinematography  recordings showed that 
the average velocity of cells cultured for 2 wk in the presence 
of  aFGF  dropped  from  30  to  10  /~m/h  after  a  2  h 
exposure to 10 i~g/ml cholera toxin. Moreover, the vimentin 
intermediate filaments that were induced by long-term cul- 
ture with aFGF (see reference 7), underwent dramatic modi- 
fications. As an example, Fig. 7 shows the immunoreactive 
pattern obtained by incubating cells with cholera toxin: the 
network of filaments running through the cytoplasm was re- 
placed by a dense immunoreactivity accumulated in a region 
near the nucleus; some cells were even devoid of vimentin 
immunostaining (Fig. 7, compare g  and h). 
aFGF Does Not Significantly Modify Basal or 
Activated Adenylate Cyclase Activity 
Due to the discriminating effects of cAMP-elevating agents 
on the dual function of aFGF, it was of importance to deter- 
mine whether intracellular cAMP content was affected by 
aFGE  In  the  absence  of adenylate  cyclase  activator,  no 
significant increase of the basal cAMP production could be 
detected upon addition of aFGF to sparse or confluent G0- 
arrested cells  (Table II).  Stimulation of adenylate cyclase 
activity by forskolin (10  ftM)  or  cholera toxin  (1  /~g/ml) 
resulted in the expected augmentation of intracellular cAMP 
content. The presence of aFGF (30 ng/mi) did not signifi- 
cantly modify forskolin or cholera toxin-stimulated CAMP 
production, even in the presence of the phosphoesterase in- 
hibitor IBMX,  which was included at  1 mM to allow ac- 
cumulation of intracellular CAMP. These results suggest that 
aFGF-induced stimulation of its cognate receptors does not 
generate  a  modification  in  the  adenylate cyclase  system. 
Therefore, the synergy between cAMP-elevating agents and 
aFGF in the reinitiation of DNA synthesis is likely to arise 
from events involved downstream in the cAMP transducing 
pathway. 
Interestingly, subconfluent cultures had an elevated con- 
tent of intracellular CAMP as compared with confluent cul- 
tures  (Table ID.  The amount of cAMP in  sparse  cells is 
nevertheless too small to prevent cells from being dispersed 
by aFGF at a concentration of 10 ng/ml. However, in other 
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in  a  more  physiological  range  than  those  used  here,  the 
amounts of intracellular cAMP could be sufficient to inhibit 
the scattering effect of this growth factor. 
Discussion 
aFGF  promotes  two  different  biological  responses  in  the 
Table L cAMP-elevating  Agents Do Not Influence aFGF 
Binding on NBT-H Cells 
Treatment  Binding of radiolabeled aFGF 
cpm  4- SE 
--  12696  +  56 
pertussis toxin  11795 +  289 
cholera toxin  13552 +  1279 
forskolin  14291  +  211 
Binding of 10 ng/rrd mI-aFGF on the  surface of NBT-II ceils preincubated 
for 4 h with 100 ng/ml pertussis toxin,  10 gg/ml cholera toxin, or 100 I~M for- 
skolin. The number of cpm bound is determined under conditions described in 
Materials and Methods and represents the mean value of three identical wells 
4-  standard  error. 
Figure 6.  Closure  of in vitro 
wounds  made  in  monolayers 
of NBT-II cells. Cell cultures 
were fixed and examined 18 h 
after  producing  an  artificial 
wound  in  cultures  incubated 
with  standard  medium  (a). 
Alternatively,  wounded  cell 
cultures were stimulated with 
10 ng/ml aFGF alone (b),  or 
plus  10  gg/ml cholera  toxin 
(c),  plus  100 ng/ml pertussis 
toxin (d), plus I mM 8-bromo 
cAMP (e),  plus  1 mM dibu- 
tyryl-cAMP (f). Bar, 200 gm. 
NBT-II rat bladder carcinoma cell line. At confluency, it in- 
duces reentry to cell division while at subconfluency, it trig- 
gers cell scattering (42). Resistance of subconfluent cultures 
to the mitogenic effect of aFGF does not arise from the intrin- 
sic inability  of sparse G0-arrested cells to reinitiate  DNA 
synthesis. Indeed, bradykinin, a rnitogenic peptide that stim- 
ulates the hydrolysis of phosphoinositides (5) promotes the 
proliferation of sparse cultures of NBT-II cells and has no 
dispersing  effect (data  not  shown).  This  result  raises  the 
attractive possibility that  the  induction  of EMT would be 
coupled to inhibition of proliferation and furthermore would 
be under the control of factors binding tyrosine kinase re- 
ceptors. 
The two functions of aFGF are mutually exclusive since 
the  growth  factor cannot  simultaneously  elicit  dispersion 
and  DNA synthesis.  The opposing activities of aFGF de- 
pending on the status of the cell cannot be accounted for by 
differences in prevalence or affinity of aFGF receptors on the 
surface of confluent versus subconfluent cells (42).  More- 
over, NBT-II cells are devoid of receptors recognizing basic 
FGF  (bFGF)  (41)  and  do  not  scatter  in  response to  this 
growth factor. Transfection of NBT-II cells with a plasmid 
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wards  a  dispersed  state  is 
reversed  by  cAMP-elevating 
agents, NBT-II  cells were  main- 
tained  in the presence of 10 
ng/ml aFGF for 2 wk before 
addition  of various  reagents 
for 6 h. Cells were fixed and 
processed for immunofluores- 
cence microscopy with a mAb 
against DPs (a-f) or vimentin 
(g and h).  (a and g) Control 
cells  permanently  stimulated 
by aFGF; (b and h) addition of 
10  tLg/ml cholera  toxin;  (c) 
addition of 100 I~M forskolin; 
(d) addition of 100 ng/ml per- 
tussis  toxin;  (e)  addition  of 
1 mM  8-bromo  cAMP;  and 
(/") addition of 100/~M  gen- 
istein. 
encoding the well-defined receptor for acidic and  basic FGF 
fig induces cells to disperse in response to bFGF stimulation 
(Savagner, P., A. M, Vallds, J. Jouanneau, Y. Yamada, and 
J. P. Thiery, unpublished data). These data indicate that the 
scattering activity of growth factors toward the NBT-II cell 
line can be triggered by receptors endowed with a mitogenic 
activity and is therefore not harbored by a  special type of 
receptor. It is thus important to determine whether the alter- 
native action of aFGF is dependent on alternative signaling 
pathways. 
Our results clearly demonstrate the role of tyrosine phos- 
phorylation in both responses.  Tyrosine phosphorylations 
have already been shown to be implicated in the mitogenic 
response of 3T3 cells to aFGF (11). This is not an unexpected 
result, since FGFs bind to receptors endowed with a tyrosine 
kinase activity (20, 40). Moreover, our results indicate that 
sustained tyrosine phosphorylation activity is able to repro- 
duce by itself the scattering effect of aFGE These data are 
consistent with the observation that sodium orthovanadate 
dissociates MDCK cells and reproduces the alterations of 
Table II. Effect of  aFGF on the Basal and Stimulated Adenylate Cyclase Activity in Sparse and Confluent 
Cultures of  NBT-II Cells 
Condition  Confluent culture  Subconfluent culture 
pmol cAMP~10  s cells  pmol/1os cells 
+  IBMX  0.03  +  0.005  0.18  •  0.04 
+  IBMX  +  aFGF  0.05  +  0.004  0.18  +  0.05 
+  IBMX  +  forskolin  1.5  +  0.4  1.8  •  0.25 
+  IBMX  +aFGF  +  forskolin  1.8  +  0.3  1.6  +  0.3 
+  IBMX  +  cholera toxin  1.6  +  0.4  1.1  +  0.3 
+  IBMX  +  aFGF  +  cholera toxin  2.0  +  0.5  1.0  •  0.2 
Two million  c~lls  (confluent  cultures)  or  2 ￿  105  cells  (subconfluent  cultures)  were preincubated for  30  rain  in  DME  before receiving the  various agents,  Cholera 
toxin (1 /~g/ml) was present during the 30-rain incubation, aFGF (30 ng/ml) was added for 15 rain before addition of IBMX (1 raM). Forskolin (10 ~M) was 
added 15 rain after IBMX. The accumulation of cAMP was measured 10 rain after addition of IBMX (when forskolin was omitted) or 10 rain after addition of 
forskolin.  Determination of  cAMP  content was  done  by  radioimmunoassay as  described in  Materials and Methods. Values are  the  means :[:  standard error  of  four 
different  determinations. 
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transformed chick cells (43, 44). Since one of the primary 
events in aFGF-induced scattering consists of the removal of 
desmosomal components from the cell periphery (7), our 
results suggest that intercellular junctions may be direct tar- 
gets for growth factor action. Involvement of a specific sig- 
naling pathway in the disruption of intercellular contacts 
induced  by  low  extracellular  calcium  had  already  been 
reported 00).  On the other hand, cell adhesion molecules 
that participate in establishing cell-cell interactions mediate 
their function through pertussis-sensitive  G  protein  (12), 
suggesting that modifications in the balance of messenger 
molecules could in turn be directly reflected by changes in 
intercellular adhesiveness. 
From our results,  it appears  clear that tyrosine kinase- 
modulating agents cannot distinguish between the two re- 
sponses elicited by aFGE In an attempt to demonstrate that 
the transducing pathways of  aFGF leading to the two biologi- 
cal responses of NBT-II cells are different, we found that 
TGF-/31 has the unique property of blocking aFGF-induced 
DNA  replication without affecting aFGF-mediated EMT. 
Because they are not equally sensitive to TGF-/~I, the two bi- 
ological responses of NBT-II cells are therefore not triggered 
by the same set of transducing molecules. Mysterious for a 
long time, the nature of the signaling mechanisms of TGF~ 
is now being progressively elucidated (28, 30).  Most inter- 
estingly, the growth inhibitory signals of TGF-/~I are likely 
to take place late during the cell cycle by preventing the phos- 
phorylation of pRB (24).  This result suggests that the two 
pathways of aFGF in NBT-II  cells diverge at a branching 
point taking place before late (31 phase. 
Activation or inhibition of PKC did not have any effect on 
the two responses elicited by aFGF in NBT-II cells (data not 
shown). Consequently, we sought to determine whether the 
effect of cAMP-elevating agents on the two responses  to 
aFGF could provide additional evidence for the existence of 
a diverging point in the transduction pathways of aFGE Our 
results point out to the discriminative effect of sustained ele- 
vation of cAMP:  cAMP-elevating agents indeed synergize 
with aFGF to trigger DNA synthesis and strongly repress 
aFGF-induced  EMT.  Moreover,  cAMP  elevation  is  also 
capable of reversing the fibroblastic-like phenotype, indicat- 
ing that the level of  cAMP not only regulates EMT but is also 
probably  involved  in  the  maintenance  of  the  epithelial 
phenotype. 
Implication of cAMP in FGF-induced mitogenesis has 
been a subject of controversy (25, 36). More generally, it ap- 
pears that cAMP could be involved in epithelial but not in 
fibrohlastic mitogenesis (14). However, there are exceptions 
to this rule. For example, cAMP-elevating agents still poten- 
tiate aFGF-induced DNA synthesis in fibroblastic-like NBT- 
II cells that have been maintained in the presence of aFGF 
for one month (data not shown); cAMP enhancers also syn- 
ergize with insulin to induce DNA synthesis in 3T3 fibro- 
blasts (32). 
Cyclic AMP not only regulates cell division but also cell 
differentiation. In many cells, there is an obvious link be- 
tween growth and inhibition of differentiation or conversely, 
between growth arrest  and differentiation processes.  Our 
system provides evidence for such a  linkage, since cAMP 
elevation  stimulated DNA  synthesis and  inhibited EMT, 
which can be regarded as a process of differentiation. In ad- 
dition it should be stressed that the status of the cell itself 
participates in the choice between proliferation and differen- 
tiation (42).  In agreement with our results, O'Neill and co- 
workers reported that elevation in intracellular cAMP stimu- 
lates the proliferation of quiescent fibroblasts and inhibits 
their motility (32). 
Measurements  of intracellular  cAMP  content  in  sub- 
confluent and confluent cultures indicated that no change in 
the cAMP level was detected in FGF-stimulated cells, even 
in the presence of cAMP-elevating agents. The discrepancy 
between our results and others' (26) might arise from the fact 
that in our system cAMP stimulates cell proliferation while 
in the other report it was a strong inhibitor of FGF-induced 
mitogenesis. The absence of effect of aFGF on cAMP pro- 
duction suggests that the pathways of aFGF and cAMP are 
largely separate. Moreover, our results raise the question as 
to whether cAMP elicits its discriminative effects on aFGF 
functions by activating cyclic AMP-dependent protein ki- 
nases (PKA) or by acting on gene expression. Cyclic AMP 
could indeed display both stimulatory and inhibitory effects 
by acting only on DNA transcription:  whereas transcrip- 
tional activation of cyclic AMP-responsive element (CRE)- 
containing genes is a  common effect of cAMP,  cAMP in- 
hibits fibronectin gene expression in a granulosa cell line by 
acting indirectly on a DNA sequence other than CRE (3). 
Therefore, it would be interesting to study induction of gene 
expression in aFGF-stimulated NBT-II ceils in the presence 
or absence of cAMP-elevating agents. 
There is increasing evidence that many signals emanating 
from a single growth factor receptor follow multiple cellular 
pathways. This could explain the pleiotropic effects of growth 
factors that elicit their biological responses by inducing a 
wide range of cellular modifications. The molecular bases 
underlying the generation of complex networks of  branching 
pathways are far from being elucidated. However,  there is 
evidence that divergence of the signals might occur at the 
receptor level (40,  47).  In the case of the dual response 
elicited by aFGF in NBT-II ceils, our experiments suggest the 
existence of a precocious branching point that can be arti- 
ficially modulated by elevation of intracellular cAMP.  It is 
therefore conceivable that signal transfer particles created 
between the stimulated receptor and intracellular effector 
molecules might specify the type of biological response. 
This hypothesis is under current investigation. 
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